🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in Canada / NCT07097402
Starting soon Not applicable

Examination of a Self-Compassion Course for Healthcare Providers Working With People With Multiple Sclerosis

NCT07097402 · tracked via the Priya Life Science Canada tracker
Sponsor
Robert Simpson
Phase
Not applicable
Started
2025-09-01
Last updated
2025-07-31

Condition(s) studied

BurnoutCompassion

Investigational drug(s) / intervention(s)

Self-compassion intervention (Self-Compassion for Healthcare Communities course)

Self-compassion intervention (Self-Compassion for Healthcare Communities course): An online 6-week mindful self-compassion course with weekly sessions.

Study summary

Clinical staff working with people with multiple sclerosis often face emotional fatigue and high levels of burnout. The Self-Compassion for Healthcare Communities course is an evidence-based intervention that teaches participants how to meet distress with kindness and care. This study will recruit up to 40 staff from the Barlo MS Clinic at St. Michael's Hospital to take part in a 6-week, 6-session Self-Compassion for Healthcare Communities course. Participants will be asked to complete surveys before and after the course to understand the effects of the course on a range of outcomes. Participants will be invited to take part in one qualitative interview on their perspectives on the course.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: 1. Aged 18 years or older 2. Able to understand spoken and written English 3. Current professional affiliation with the Barlo MS clinic Exclusion Criteria: 1\) Severe active mental health impairment (psychosis, suicidality)

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Unity Health Toronto Toronto Ontario

More Robert Simpson trials in Canada

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07097402 on ClinicalTrials.gov ↗ ← All trials in Canada